News

EVerZom, a biopharmaceutical company developing  exosome based biodrugs, announces that it has reached a key milestone in its development with the production of a first exosome GMP batch in a 10L bioreactor with unprecedented yields. Regulatory validation of the technology was carried out in GMP clean rooms of...

Emmes, part of Emmes Group, a leading specialty tech-enabled global contract research organization (CRO), has been selected by the National Institutes of Health’s (NIH) NIDA to support their Clinical Trials Network (CTN) for a multi-task, IDIQ contract. The management of NIDA Clinical Trial Network is supported by the Data and Statistical Coordinating Center (DSC) and the Clinical Coordinating...

Determining the value of a medicine may be a challenging task. To put it another way, how much is the value of a patient's life? Adding real-world data to the standard equation in order to provide a more focused...

Artificial Intelligence (AI) is transforming the pharmaceutical industry, driving significant advancements across various stages of drug discovery, development, and production. By leveraging AI technologies, pharmaceutical companies can streamline processes, reduce costs, and enhance the accuracy and speed of drug...

Lonza is revolutionizing drug development with its AI-driven route scouting technology, allowing pharmaceutical companies to fast-track their investigational new drug (IND) submissions. By integrating artificial intelligence (AI) into their processes, Lonza has been able to significantly reduce the time...

Despite their track record of demonstrating significant therapeutic efficacy, biologics still face daunting challenges in their drug delivery. Biologics such as monoclonal antibodies (mAbs) and some vaccines are largely administered via injection or by infusion. These methods can often...

The pharmaceutical sector is still a hub for new patent developments. The development of novel treatment paradigms, the severity of unfulfilled requirements, and the increasing significance of technology like pharmacogenomics, digital therapies, and artificial intelligence are what propel activity....